Abstract
Eplerenone, a potassium-sparing diuretic similar to spironolactone, selectively blocks aldosterone to lower blood pressure. However, its safety profile is improved over spironolactone because of reduced progesterone and androgen-receptor effects. It is labeled for treatment of hypertension, either alone or in combination. It has been studied in postmyocardial infarction (MI) patients with left ventricular dysfunction.
| Original language | English |
|---|---|
| Pages (from-to) | 915-916 |
| Number of pages | 2 |
| Journal | American Family Physician |
| Volume | 69 |
| Issue number | 4 |
| State | Published - 15 Feb 2004 |